Pfizer

Oncology Research and Development Postdoctoral Program

Puja Sapra, Ph.D.
Vice President and CSO, Targeted Therapeutics Unit

Education

Undergrad: B.S. Human Biology, All India Institute of Medical Sciences, Delhi, India
Graduate: M.S. Pharmacology, University of Strathclyde, Glasgow, UK
Ph.D. Pharmacology, University of Alberta, Canada

Research Interests:

I lead the Targeted Therapeutics Discovery Group at the Oncology R&D site in Pearl River, NY, where I am building a program to develop novel targeted therapies, including Antibody Drug Conjugates (ADCs), Bispecific antibodies, Immunotherapies and Nanoparticles targeting tumor, immune and stromal cells. The postdoctoral program is designed to enable our scientists to explore how they can best utilize their individual skills and talents to impact our high-paced research environment. Importantly, we want to provide an ideal environment for postdocs to obtain exposure to the dynamics of the drug development process. An important goal for our postdoc projects is discovery of novel biology to help guide the development of innovative cancer therapies that significantly impact the lives of cancer patients.

Selected Publications